MedPath

Group psychoeducation versus group support using expert patients and clinical staff in the management of bipolar disorder

Not Applicable
Completed
Conditions
Bipolar affective disorder
Bipolar disorder
Mental and Behavioural Disorders
Registration Number
ISRCTN62761948
Lead Sponsor
niversity of Nottingham (UK)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
358
Inclusion Criteria

1. Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders, 4th Edition (SCID-DSM-IV) verified diagnosis of primary bipolar disorder
2. Increased risk of relapse (at least one episode in the last 24 months)
3. Age over 18 years, either sex

Exclusion Criteria

1. Presence of a current manic, hypomanic, mixed affective or major depressive episode currently or within the previous 8 weeks
2. Current suicide plans or high suicide intent
3. Inability or unwillingness to give written informed consent to the study
4. Participants would have to be able to communicate in written and verbal English to a sufficient level to allow them to complete the measures and take part in the groups

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Time to next bipolar episode and average weekly symptom score, both established using four monthly SCID LIFE interviews to generate weekly scores of mania and depression on 1 - 6 scale of severity<br>2. Primary economic measure of incremental cost per quality adjusted life year gained<br><br>Follow-up of each patient will be for 24 months from randomisation. Patients who had not relapsed at 24 months will be censored on the time to next episode outcome. The peak effect of psychoeducation on time to next bipolar episode have been observed at 24 months after randomisation. Baseline interview using the SCID will assess the presence of axis 1 and axis 2 comorbid psychopathology and the number of previous bipolar episodes.
Secondary Outcome Measures
NameTimeMethod
1. Assessment of weekly symptoms using the LIFE<br>2. Assessment of function using the Social Adjustment Scale, and Social and Occupational Functioning Assessment Scale (SOFAS)<br>3. Observer and self-rated measures of mood: 17-item Hamilton Depression Scale (HDRS), Bech-Raphaelson Mania Scale (MAS), Beck Depression Inventory (BDI) and PHQ-9 (Personal Health Questionnaire)<br>4. Medication adherence<br><br>Schedule of assessment:<br>At baseline, 12 and 24 months (face to face assessments): SAS, Economic Interview (CSRI), EuroQol<br>At 4, 8, 16, and 20 months (telephone assessments): LIFE, HDRS, MAS, SOFAS, MedAd, BDI version 1(by post), PHQ-9 (by post)
© Copyright 2025. All Rights Reserved by MedPath